CD79A and nasopharyngeal carcinoma: Although VCA-IgA (EBV viral capsid antigen) and EA-IgA (EBV early antigen) were used as common screening and diagnosis markers for NPC, the lack of specificity of the VCA-IgA assay and sensitivity of the EA-IgA assay limits their effectiveness in NPC diagnosis 2,3.